Skip to main content
Top
Published in: Clinical and Translational Oncology 10/2009

01-10-2009 | Correspondence

Plasmacytoid lymphoma treated with rituximab as first-line monotherapy

Authors: I. Blancas López-Barajas, Irene Zarcos, Francisco J. Gómez, María Teresa Delgado, Josefa Carrillo, Marta Legerén, Belén Ríos, Eduardo Pacios, José Miguel Jurado, María José Sánchez, Rocío Fonseca, José Luis García Puche

Published in: Clinical and Translational Oncology | Issue 10/2009

Login to get access
Metadata
Title
Plasmacytoid lymphoma treated with rituximab as first-line monotherapy
Authors
I. Blancas López-Barajas
Irene Zarcos
Francisco J. Gómez
María Teresa Delgado
Josefa Carrillo
Marta Legerén
Belén Ríos
Eduardo Pacios
José Miguel Jurado
María José Sánchez
Rocío Fonseca
José Luis García Puche
Publication date
01-10-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 10/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0429-4

Other articles of this Issue 10/2009

Clinical and Translational Oncology 10/2009 Go to the issue

News and Views

Oncologic summa

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine